Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS Inhibitors for Liver Fibrosis in HCV
NCT03770936Phase 3Recruiting
- Start
- Oct 2018
- Primary completion
- Oct 2026
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan, ramipril in Liver Fibrosis (LF). Started Oct 2018; status: recruiting.
02
Drugs
candesartanramipril
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT03770936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770936.